These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 20578837)

  • 1. Activated PI3K/Akt/COX-2 pathway induces resistance to radiation in human cervical cancer HeLa cells.
    Xia S; Zhao Y; Yu S; Zhang M
    Cancer Biother Radiopharm; 2010 Jun; 25(3):317-23. PubMed ID: 20578837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphoinositide-3-kinase inhibition enhances radiosensitization of cervical cancer in vivo.
    Liu Y; Cui B; Qiao Y; Zhang Y; Tian Y; Jiang J; Ma D; Kong B
    Int J Gynecol Cancer; 2011 Jan; 21(1):100-5. PubMed ID: 21330835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celecoxib Down-Regulates the Hypoxia-Induced Expression of HIF-1α and VEGF Through the PI3K/AKT Pathway in Retinal Pigment Epithelial Cells.
    Sun YZ; Cai N; Liu NN
    Cell Physiol Biochem; 2017; 44(4):1640-1650. PubMed ID: 29216640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-gastric cancer effects of celecoxib, a selective COX-2 inhibitor, through inhibition of Akt signaling.
    Kim N; Kim CH; Ahn DW; Lee KS; Cho SJ; Park JH; Lee MK; Kim JS; Jung HC; Song IS
    J Gastroenterol Hepatol; 2009 Mar; 24(3):480-7. PubMed ID: 18823436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib radiosensitizes the human cervical cancer HeLa cell line via a mechanism dependent on reduced cyclo-oxygenase-2 and vascular endothelial growth factor C expression.
    Wang AH; Tian XY; Yu JJ; Mi JQ; Liu H; Wang RF
    J Int Med Res; 2012; 40(1):56-66. PubMed ID: 22429345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting PI3K/Akt pathway increases DNA damage of cervical carcinoma HeLa cells by drug radiosensitization.
    Xia S; Yu S; Fu Q; Liu F; Zheng W; Fu X; Zhao Y
    J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):360-4. PubMed ID: 20556582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines.
    Lee CM; Fuhrman CB; Planelles V; Peltier MR; Gaffney DK; Soisson AP; Dodson MK; Tolley HD; Green CL; Zempolich KA
    Clin Cancer Res; 2006 Jan; 12(1):250-6. PubMed ID: 16397049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of the LY294002 - A Non-Selective Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) Pathway- in Cell Survival and Proliferation in Cell Line SCC-25.
    Duarte A; Silveira GG; Soave DF; Costa JPO; Silva AR
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3377-3383. PubMed ID: 31759362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1.
    Arunasree KM; Roy KR; Anilkumar K; Aparna A; Reddy GV; Reddanna P
    Leuk Res; 2008 Jun; 32(6):855-64. PubMed ID: 18083230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting integrins and PI3K/Akt-mediated signal transduction pathways enhances radiation-induced anti-angiogenesis.
    Ning S; Chen Z; Dirks A; Husbeck B; Hsu M; Bedogni B; O'Neill M; Powell MB; Knox SJ
    Radiat Res; 2007 Jul; 168(1):125-33. PubMed ID: 17722999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
    Liu B; Shi ZL; Feng J; Tao HM
    Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.
    Zhou C; Qiu L; Sun Y; Healey S; Wanebo H; Kouttab N; Di W; Yan B; Wan Y
    Int J Oncol; 2006 Jul; 29(1):269-78. PubMed ID: 16773209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours.
    Kucab JE; Lee C; Chen CS; Zhu J; Gilks CB; Cheang M; Huntsman D; Yorida E; Emerman J; Pollak M; Dunn SE
    Breast Cancer Res; 2005; 7(5):R796-807. PubMed ID: 16168126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated phosphatidylinositol 3-kinase activation and its clinicopathological significance in cervical cancer.
    Zhang XY; Zhang HY; Zhang PN; Lu X; Sun H
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):237-44. PubMed ID: 18395956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Telomerase activity,PI3K/AKT signaling pathway and cellular biological behavior in HeLa cell line].
    Yu XX; Shi YA; Zhang LH; Wang YS; Wu S
    Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):323-7. PubMed ID: 18956651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic fibroblast growth factor inhibits radiation-induced apoptosis of HUVECs. I. The PI3K/AKT pathway and induction of phosphorylation of BAD.
    Gu Q; Wang D; Wang X; Peng R; Liu J; Jiang T; Wang Z; Wang S; Deng H
    Radiat Res; 2004 Jun; 161(6):692-702. PubMed ID: 15161350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H₂₂ murine hepatocarcinoma model.
    Sui W; Zhang Y; Wang Z; Wang Z; Jia Q; Wu L; Zhang W
    Oncol Rep; 2014 May; 31(5):2252-60. PubMed ID: 24647425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
    Martelli AM; Tazzari PL; Tabellini G; Bortul R; Billi AM; Manzoli L; Ruggeri A; Conte R; Cocco L
    Leukemia; 2003 Sep; 17(9):1794-805. PubMed ID: 12970779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of PI3K/Akt and p38 MAPK in the induction of COX-2 expression by bacterial lipopolysaccharide in murine adrenocortical cells.
    Mercau ME; Astort F; Giordanino EF; Martinez Calejman C; Sanchez R; Caldareri L; Repetto EM; Coso OA; Cymeryng CB
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):43-51. PubMed ID: 24424443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
    Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S
    Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.